Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Suyeon Je"'
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Primary cilia have essential roles as signaling centers during development and adult homeostasis. Disruption of ciliary structure or function causes congenital human disorders called ciliopathies. Centriolar distal appendage (DAP) proteins are import
Externí odkaz:
https://doaj.org/article/318ca573bd304b89ad05d928ac75d72e
Autor:
Zhezhu Han, Dongxu Kang, Yeonsoo Joo, Jihyun Lee, Geun-Hyeok Oh, Soojin Choi, Suwan Ko, Suyeon Je, Hye Jin Choi, Jae J. Song
Publikováno v:
Experimental and Molecular Medicine, Vol 50, Iss 12, Pp 1-19 (2018)
Cancer: Tipping the signaling balance Reducing the levels of the multifunctional protein transforming growth factor (TGF)-β in cancer cells prevents tumor growth in mice. Previous studies have shown that high levels of TGF-β in cancerous tissue are
Externí odkaz:
https://doaj.org/article/88e935c017ed4a64845a571c7fa1db78
Publikováno v:
Nutrition & Diabetes, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Background Fenofibrate is a hypolipidemic peroxisome proliferator-activated receptor α (PPARα) agonist used clinically to reduce hypercholesterolemia and hypertriglyceridemia. Objective We investigated the effects of fenofibrate on insulin
Externí odkaz:
https://doaj.org/article/9fa04eaaa6be409185372f23c3a83bb7
Autor:
Hye Jin Choi, Soo Jin Choi, Dongxu Kang, Geun-Hyeok Oh, Zhezhu Han, Suwan Ko, Suyeon Je, Jihyun Lee, Jae J. Song, Yeonsoo Joo
Publikováno v:
Experimental and Molecular Medicine, Vol 50, Iss 12, Pp 1-19 (2018)
Experimental & Molecular Medicine
Experimental & Molecular Medicine
Transforming growth factor (TGF)-β signaling is increasingly recognized as a key driver in cancer. In progressive cancer tissues, TGF-β promotes tumor formation, and its increased expression often correlates with cancer malignancy. In this study, w
Publikováno v:
Apoptosis. 21:351-364
In this study, we demonstrated that survivin downregulation with TRAIL expression greatly enhanced the cytotoxic death of pancreatic cancer cells after gemcitabine treatment. Using real-time RT-PCR, we analyzed five survivin shRNAs to identify the be
Publikováno v:
Osong Public Health and Research Perspectives, Vol 13, Iss 2, Pp 133-141 (2022)
Objectives We described the trends and epidemiological characteristics of varicella outbreaks from 2016 to 2020 in the Republic of Korea. Methods We investigated variables such as the outbreak setting, age of patients, vaccination status, and lesion
Externí odkaz:
https://doaj.org/article/fb57dadef46b40de84c299a08fc1d151
Publikováno v:
Cellular signalling. 27(6)
We previously showed that an increase of cellular Bcl-xL mediates acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and knockdown of Bcl-xL expression greatly sensitized TRAIL-induced cytotoxicity. Here, we show t
Autor:
Hye Jin Choi, Suyeon Je, So Young Kim, Dongxu Kang, Jae J. Song, Yong sic Hwang, Zhezhu Han, Joo Hang Kim, Sujin Kang
Publikováno v:
Cellular signalling. 27(4)
Gemcitabine has been used most commonly as an anticancer drug to treat advanced pancreatic cancer patients. However, intrinsic or acquired resistance of pancreatic cancer to gemcitabine was also developed, which leads to very low five-year survival r
Autor:
Byung Ha Chung, Jian Huang, Zhang-Qun Ye, Da-Lin He, Hirotsugu Uemura, Gaku Arai, Choung Soo Kim, Yuan-Yuan Zhang, Yusoke Koroki, SuYeon Jeong, Suneel Mundle, Spyros Triantos, Sharon McCarthy, Kim N Chi, Ding-Wei Ye
Publikováno v:
Asian Journal of Andrology, Vol 24, Iss 2, Pp 161-166 (2022)
Ethnicity might be associated with treatment outcomes in advanced prostate cancer. This study aimed to evaluate the efficacy and safety of androgen deprivation therapy (ADT) combined with apalutamide in East Asians with metastatic castration-sensitiv
Externí odkaz:
https://doaj.org/article/9018fc34a228416d9d780426e11c2984
Publikováno v:
Cancer Immunology Research. 5:B81-B81
As combining therapeutic agents with different action mechanisms may enhance efficacy, YSC-02, an oncolytic adenovirus with multi targets was loaded with five different genes, which were designed with the expectation that different action mechanisms